# Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk

> **NCT06867835** · PHASE4 · COMPLETED · sponsor: **Cosette Pharmaceuticals, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Lactating Mother

## Interventions

- **DRUG:** Vyleesi (Bremelanotide Injection)

## Key facts

- **NCT ID:** NCT06867835
- **Lead sponsor:** Cosette Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-11
- **Primary completion:** 2025-11-15
- **Final completion:** 2025-11-15
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06867835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06867835, "Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT06867835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*